Volume | 202,689 |
|
|||||
News | - | ||||||
Day High | 0.012 | Low High |
|||||
Day Low | 0.0108 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CeCors Inc (PK) | CEOS | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.011 | 0.0108 | 0.012 | 0.0114 | 0.012 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
11 | 202,689 | $ 0.011028 | $ 2,235 | - | 0.0077 - 0.0977 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:14:57 | 10,000 | $ 0.0114 | USD |
CeCors Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.32M | 332.08M | 148.29M | 19k | -498k | -0.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CeCors (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CEOS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.013 | 0.0135 | 0.0108 | 0.0118594 | 400,467 | -0.0016 | -12.31% |
1 Month | 0.0125 | 0.0154 | 0.008975 | 0.0120794 | 407,074 | -0.0011 | -8.8% |
3 Months | 0.0178 | 0.0185 | 0.0077 | 0.0127782 | 381,666 | -0.0064 | -35.96% |
6 Months | 0.0299 | 0.0465 | 0.0077 | 0.0260382 | 568,949 | -0.0185 | -61.87% |
1 Year | 0.0131 | 0.0977 | 0.0077 | 0.0434696 | 1,229,464 | -0.0017 | -12.98% |
3 Years | 0.00755 | 0.485 | 0.0035 | 0.0513822 | 785,951 | 0.00385 | 50.99% |
5 Years | 0.1175 | 0.485 | 0.0005 | 0.044154 | 678,723 | -0.1061 | -90.3% |
CeCors (PK) Description
PsyKey Inc. is vertically integrated in the research & development, production, and commercialization of therapeutic and medicinal entheogenic, adaptogenic, nootropic ingredients and formulations for its premium functional product lines which are developed by its mycology and botany experts. PsyKey understands the importance of access to support services and healthcare professionals and is continuously engaged in the development of tools that will aid in removing barriers and providing inclusivity. PsyKey is also engaged in the scientific development of patentable technologies pertaining to the composition, bioavailability and targeted delivery of entheogen-based therapeutics. Recently the Company acquired Vetcomm. VetComm is a veteran's education, and benefits company focused on assisting the over 20 million United States veterans that qualify for underutilized annual benefits and owed compensation. As a result, billions of dollars in veteran benefits go unclaimed every month in the United States. |